Quest Diagnostics Inc (LTS:0KSX)
$ 152.97 0 (0%) Market Cap: 17.12 Bil Enterprise Value: 23.44 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 83/100

Quest Diagnostics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 08:40PM GMT
Release Date Price: $127.49 (-2.04%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Okay. So hi, everyone. Thank you for joining us today. My name is Erin Wright. I am Morgan Stanley's Healthcare Services and Distribution analyst. I am pleased to have with us Quest's CEO, James Davis; as well as CFO, Sam Samad, here with us today. So thank you for joining us, a relatively kind of newer team at Quest.

Before we get started, for important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Erin Elizabeth Wilson Wright;Sam A. Samad
Morgan Stanley, Research Division - Equity Analyst;Quest

And with that, I'll go ahead and get started with Q&A, if that works for you. And I want to give Sam some opportunity to speak here in terms of you're new to Quest. Let's talk about why Quest, why you came on board, some context around the transition and how it's going so far?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot